Substituted piperidines as modulators of the melanocortin receptor

Details for Australian Patent Application No. 2002319695 (hide)

Owner Amgem, Inc.

Inventors Fotsch, Christopher H.; Smith,Duncan M.; Xi, Ning; Kelly, Michael G.; Croghan, Michael; Xu, Shimin; Norman, Mark H.; Tamayo, Nuria; Doherty, Elizabeth M.

Agent Shelston IP

Pub. Number AU-B-2002319695

PCT Number PCT/US02/23616

PCT Pub. Number WO2003/009847

Priority 60/307,733 25.07.01 US; 10/205,649 24.07.02 US

Filing date 25 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 2 March 2006

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 211/28 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/34 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07K 5/078 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/307,733 25.07.01 US; 10/205,649 24.07.02 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002319695

2 March 2006 Application Accepted

  Published as AU-B-2002319695

9 March 2006 Corrigenda

  Applications Accepted - Name Index Under the name Amgem, Inc., Application No. 2002319695, under INID (71) correct the name to read Amgen, Inc.

29 June 2006 Standard Patent Sealed

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002319696-Systems for in vivo site-directed mutagenesis using oligonucleotides

2002319694-Method and apparatus for indicating or covering a percutaneous puncture site